Elimination diets in autism spectrum disorders: Any wheat amidst the chaff?

Journal of Developmental and Behavioral Pediatrics

Volumn 27, Issue 2 SUPPL. 2, 2006, Pages

  Christison, George W ^a   Ivany, Kristin ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative medicine; Autism spectrum disorder; Complementary; Elimination diets

Indexed keywords

CASEIN; GLUTEN; PLACEBO;

ALTERNATIVE MEDICINE; AUTISM; CAREGIVER; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITION; DIET; DIET RESTRICTION; DIETARY INTAKE; GLUTEN FREE DIET; HUMAN; METHODOLOGY; NONVERBAL COMMUNICATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN RESTRICTION; REVIEW; SYMPTOM;

EID: 33750308035     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004703-200604002-00015     Document Type: Review

References (82)

1. Levy SE, Hyman SL. Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing. Pediatr Ann. 2003;32:685-591.
2. Levy SE, Mandell DS, Merhar S, et al. Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. J Dev Behav Pediatr. 2003;24:418-423.
3. Lewis L. Special Diets for Special Kids. Understanding and Implementing Special Diets to Aid in the Treatment of Autism and Related Developmental Disorders. Arlington, TX: Future Horizons; 1998.
4. Jackson L, Le M, Breton J. A User Guide to the GF/CF Diet for Autism, Asperger Syndrome and AD/HD. London, England: Jessica Kingsley; 2002.
5. Seroussi K. Unraveling the Mystery of Autism and Pervasive Developmental Disorder: A Mother's Story of Research and Recovery. New York, NY: Broadway Books; 2002.
6. Shaw W. Biological Treatments for Autism and PDD. Lenexa, KS: Great Plains Laboratory; 2002.
7. McCandless J. Children with Starving Brains: A Medical Treatment Guide for Autism Spectrum Disorder, 2nd ed. North Bergen, NJ: Bramble Books; 2002.
8. Hamilton LM. Facing Autism: Giving Parents Reasons for Hope and Guidance for Help. Colorado Springs, CO: Waterbrook Press; 2000.
9. LeBreton M. Dietary Intervention and Autism: Implementing the Gluten Free and Casein Free Diet for Autistic Children and Adults: A Practical Guide for Parents. London, England: Jessica Kingsley; 2001.
10. Edelson SM. 'Leaky gut' and the gluten-/casein-free diet [Center for the Study of Autism website]. Available at: http://www.autism.org/leakygut.html. Accessed May 24, 2005.
11. Gluten free/casein free (GF CF) dietary intervention [TACA (Talk About Curing Autism) website]. Available at: http://www.tacanow.com/gfcfdietintro. html. Accessed May 24, 2005.
12. De Hart J. Success stories [GFCF Diet website]. Available at: http://www.gfcfdiet.com/sucessstories.html. Accessed October 7, 2005.
13. Autism and the gluten-free/casein-free diet: a guide for parents, dietitians and other health professionals [Gluten-Free Pantry website]. Available at: http://www.glutenfree.com/autism.html. Accessed May 24, 2005.
14. Reichelt K, Knivsberg AM. Why use the gluten-free and casein-free diet in autism and what the results have shown so far [Autism Research Institute website]. Available at: http://www.autismwebsite.com/ari/dan/reichelt.html. Accessed May 24, 2005.
15. Autism can be aided by a gluten-free, casein-free diet [Gluten Solutions website]. Available at: http://www.glutensolutions.com/autism.html. Accessed May 24, 2005.
16. Bowers L. An audit of referrals of children with autistic spectrum disorder to the dietetic service. J Hum Nutr Diet. 2002;15:141-144.
17. Find a group [Yahoo! Groups Home Page]. Available at: http://www.groups.yahoo.com. Accessed October 14, 2005.
18. De Hart J. Support group meetings [GFCF Diet Support Group website]. Available at: http://www.gfcfdiet.com/SupportGroupMeetings.html. Accessed October 14, 2005.
19. Panksepp J. A neurochemical theory of autism. Trends Neurosci. 1979;2:174-177.
20. Brambilla F, Guareschi-Cazzullo A, Tacchini C, et al. Beta-endorphin and cholecystokinin 8 concentrations in peripheral blood mononuclear cells of autistic children. Neuropysychobiology. 1997;35:1-4.
21. Tordjman S, Anderson GM, McBride PA, et al. Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism. J Child Psychol Psychiatry. 1997;38:705-715.
22. Leboyer M, Bouvard MP, Recasens C, et al. Difference between plasma N- and C-terminally directed beta-endorphin immunoreactivity in infantile autism. Am J Psychiatry. 1994;151:1797-1801.
23. Leboyer M, Philippe A, Bouvard M, et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry. 1999;45:158-163.
24. Weizman R, Weizman A, Tyano S, et al. Humoral-endorphin blood levels in autism in autistic, schizophrenic and healthy subjects. Psychopharmacology (Berl). 1984;82:363-370.
25. Weizman R, Gil-Ad I, Dick J, et al. Low plasma immunoreactive beta-endorphin levels in autism. J Am Acad Child Adolesc Psychiatry. 1988;27:430-433.
26. Sandman CA, Barron JL, Chicz-DeMet A, et al. Brief report: plasma-beta-endorphin and cortisol levels in autistic patients. J Autism Dev Disord. 1991;21:83-87.
27. Gillberg C, Terenius L, Hagberg B, et al. CSF beta-endorphins in childhood neuropsychiatric disorders. Brain Dev. 1990;12:88-92.
28. Gillberg C. Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians. Dev Med Child Neurol. 1995;37:239-245.
29. Willemsen-Swinkels SH, Buitelaar JK, Weijnen FG, et al. Placebo-controlled acute dosage naltrexone study in young autistic children. Psychiatry Res. 1995;58:203-215.
30. Willemsen-Swinkels SH, Buitelaar JK, van Engel H. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study. Biol Psychiatry. 1996;39:1023-1031.
31. Kolmen BK, Feldman HM, Handen BL, et al. Naltrexone in young autistic children: a double-blind placebo-controlled crossover study. J Am Acad Child Adolesc Psychiatry. 1995;34:223-231.
32. Kolmen BK, Feldman HM, Handen BL, et al. Naltrexone in young autistic children: replication study and learning measures. J Am Acad Child Adolesc Psychiatry. 1997;36:1570-1578.
33. Williams PG, Allard A, Sears L, et al. Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management. J Autism Dev Disord. 2001;31:103-108.
34. Campbell M, Anderson LT, Small AM, et al. Naltrexone in autistic children: behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiatry. 1993;32:1283-1291.
35. Chabane N, Leboyer M, Mouren-Simeoni MC. Opiate antagonists in children and adolescents. Eur Child Adolesc Psychiatry. 2000;9(suppl 1):44-50.
36. Hunsinger DM, Nguyen T, Zebraski SE, et al. Is there a basis for novel pharmacotherapy of autism? Life Sci. 2000;67:1667-1682.
37. Teschemacher H, Koch G, Brantl V. Milk protein-derived opioid receptor ligands. Biopolymers. 1997;43:99-117.
38. Kitts DD. Bioactive substances in food: identification and potential uses. Can J Physiol Pharmacol. 1994;72:423-434.
39. Fukudome S, Yoshikawa M. Opioid peptides derived from wheat gluten: their isolation and characterization. FEBS Lett. 1992;296:107-111.
40. Fukudome S, Yoshikawa M. Gluten exorphin C: a novel opioid peptide derived from wheat gluten. FEBS Lett. 1993;316:17-19.
41. Whiteley P, Shattock P. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets. 2002;6:175-183.
42. Shattock P, Kennedy A, Rowell F, et al. Role of neuropeptides in autism and their relationship with classical neurotransmitters. Brain Dysfunct. 1990;3:328-345.
43. Reichelt KL, Saelid G, Lindback T, et al. Childhood autism: a complex disorder. Biol Psychiatry. 1986;4:308-319.
44. Israngkun P, Newman H, Patel S. Potential biochemical markers for infantile autism. Neurochem Pathol. 1986;5:51-70.
45. Reichelt KL, Knivsberg A-M, Lind G, Nodland M. Probable aetiology and possible treatment of childhood autism. Brain Dysfunct. 1991;4:308-319.
46. Reichelt KL, Ekrem J, Scott H. Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion. J Appl Nutr. 1990;42:1-11.
47. Knivsberg A, Wiig K, Lind G, et al. Dietary intervention in autistic syndromes. Brain Dysfunct. 1990;3:315-327.
48. D'Eufemia P, Celli M, Finocchinario R, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996;85:1076-1079.
49. Ashwood P, Anthony A, Pellicer A, Torrente F, Walker-Smith JA, Wakefield AJ. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol. 2003;23:504-517.
50. Ashwood P, Anthony A, Torrente F, Wakefield AJ. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol. 2004;24:664-73.
51. Wakefield AJ, Anthony A, Murch SH, et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol. 2000;95:2285-2295.
52. Torrente F, Ashwood P, Day R, et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry. 2002;7:375-382.
53. Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol. 2001;120:170-179.
54. Vojdani A, Bazargan M, Vojdani E, et al. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin Diagn Lab Immunol. 2004;11:515-524.
55. Singh VK. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol. 1996;66:143-145.
56. Gupta S, Aggarwal S, Rashanravan B, Lee T. Thl- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol. 1998;85:106-109.
57. Vojdani A, O'Bryan T, Green JA, et al. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci. 2004;7:151-161.
58. Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and streptococcus group A. J Neuroimmunol. 2002;129:168-177.
59. Shaw W, Kassen E, Chaves E. Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem. 1995;41:1094-1104.
60. O'Banion D, Armstrong B, Cummings RA, Stange J. Disruptive behavior: a dietary approach. J Autism Child Schizophr. 1978;3:325-337.
61. Waring RH, Klovrza LV. Sulphur metabolism in autism. J Nutr Environ Med. 2000;10:25-32.
62. Millward C, Ferriter M, Calver S, Connell-Jones G. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev. 2004;2:1-11.
63. Francis K. Autism interventions: a critical update. Dev Med Child Neurol. 2005;47:493-499.
64. Committee on Children With Disabilities, American Academy of Pediatrics. Counseling families who choose complementary and alternative medicine for their child with chronic illness of disability. Pediatrics. 2001;107:598-601.
65. McDougle CJ, Scahill L, Aman MG, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005;162:1142-1148.
66. Sallows GO, Graupner TD. Intensive behavioral treatment for children with autism: four-year outcome and predictors. Am J Ment Retard. 2005;110:417-38.
67. McEachin JJ, Smith T, Lovaas OI. Long-term outcome for children with autism who received early intensive behavioral treatment. Am J Ment Retard. 1993;97:359-372. discussion 373-391.
68. Knivsberg A, Reichelt KL, Nodland M, et al. Autistic syndromes and diet: a follow-up study. Scand J Educ Res. 1995;39:223-236.
69. Lucarelli S, Frediani T, Zingoni AM, et al. Food allergy and infantile autism. Panminerva Med. 1995;37:137-141.
70. Whiteley P, Rodgers J, Savery D, et al. A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings. Autism. 1999;3:45-65.
71. Cade R, Privette M, Fregly M, et al. Autism and schizophrenia: intestinal disorders. Nutr Neurosci. 2000;3:57-72.
72. Knivsberg A, Reichelt KL, Hoien T, et al. A randomized, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci. 2002;5:251-261.
73. Sandler AD, Bodfish JW. Placebo effects in autism: lessons from secretin. J Dev Behav Pediatr. 2000;21:347-350.
74. Mattes JA, Gittelman R. Effects of artificial food colorings in children with hyperactive symptoms. A critical review and results of a controlled study. Arch Gen Psychiatry. 1981;38(6):714-718.
75. Rowe KS. Synthetic food colourings and "hyperactivity": a double-blind crossover study. Aust Paediatr J. 1988;24(2):143-147.
76. Wilson N, Scott A. A double-blind assessment of additive intolerance in children using a 12-day challenge period at home. Clin Exp Allergy. 1989;19(3):267-272.
77. Egger J, Carter CM, Graham PJ, Gumley D, Soothill JF. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet. 1985;1(8428):540-545.
78. Egger J, Carter CH, Soothill JF, Wilson J. Effect of diet treatment on enuresis in children with migraine or hyperkinetic behavior. Clin Pediatr (Phila). 1992;31(5):302-307.
79. Schmidt MH, Mocks P, Lay B, et al. Does oligoantigenic diet influence hyperactive/conduct-disordered children - a controlled trial. Eur Child Adolesc Psychiatry. 1997;6(2):88-95.
80. Clinical research studies [UC Davis MIND Institute website]. Available at: http://www.ucdmc.ucdavis.edu/mindinstitute/research/clinicalstudies.html. Accessed October 14, 2005.
81. Projects and programs [website for the UCLID Center at the University of Pittsburgh]. Available at http://www.uclid.org:8080/uclid/re_autism.html. Accessed October 14, 2005.
82. Diet and behavior in young children with autism [NIH Clinical Trials website]. Available at: http://www.clinicaltrials.gov/ct/show/nct00090428?order= 9. Accessed October 14, 2005.